Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Accumulated Expenses (2016 - 2025)

Nephros has reported Accumulated Expenses over the past 16 years, most recently at $1.0 million for Q4 2025.

  • Quarterly results put Accumulated Expenses at $1.0 million for Q4 2025, up 728.46% from a year ago — trailing twelve months through Dec 2025 was $1.0 million (up 728.46% YoY), and the annual figure for FY2025 was $1.0 million, up 728.46%.
  • Accumulated Expenses for Q4 2025 was $1.0 million at Nephros, down from $1.2 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for NEPH hit a ceiling of $1.2 million in Q3 2025 and a floor of $36000.0 in Q4 2022.
  • Median Accumulated Expenses over the past 5 years was $424000.0 (2024), compared with a mean of $447100.0.
  • Biggest five-year swings in Accumulated Expenses: plummeted 91.89% in 2022 and later surged 1391.67% in 2023.
  • Nephros' Accumulated Expenses stood at $444000.0 in 2021, then crashed by 91.89% to $36000.0 in 2022, then surged by 1391.67% to $537000.0 in 2023, then crashed by 77.09% to $123000.0 in 2024, then skyrocketed by 728.46% to $1.0 million in 2025.
  • The last three reported values for Accumulated Expenses were $1.0 million (Q4 2025), $1.2 million (Q3 2025), and $771000.0 (Q2 2025) per Business Quant data.